Vaccine appears to 'mop up' leukemia cells Gleevec leaves behind
Saturday, January 9, 2010 - 22:21
in Health & Medicine
Preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia patients taking the drug Imatinib mesylate (Gleevec).